These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2354 related items for PubMed ID: 31691122

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.
    Chen SC, Lo CM, Wang SH, Su EC.
    BMC Bioinformatics; 2019 Dec 24; 20(Suppl 19):659. PubMed ID: 31870275
    [Abstract] [Full Text] [Related]

  • 4. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.
    Goyal A, Yolcu YU, Goyal A, Kerezoudis P, Brown DA, Graffeo CS, Goncalves S, Burns TC, Parney IF.
    Neurosurg Focus; 2019 Dec 01; 47(6):E13. PubMed ID: 31786548
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas.
    Yang X, Lin Y, Xing Z, She D, Su Y, Cao D.
    Acta Radiol; 2021 Dec 01; 62(12):1657-1665. PubMed ID: 33222488
    [Abstract] [Full Text] [Related]

  • 8. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas.
    Han Y, Xie Z, Zang Y, Zhang S, Gu D, Zhou M, Gevaert O, Wei J, Li C, Chen H, Du J, Liu Z, Dong D, Tian J, Zhou D.
    J Neurooncol; 2018 Nov 01; 140(2):297-306. PubMed ID: 30097822
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MRI radiomics analysis of molecular alterations in low-grade gliomas.
    Shofty B, Artzi M, Ben Bashat D, Liberman G, Haim O, Kashanian A, Bokstein F, Blumenthal DT, Ram Z, Shahar T.
    Int J Comput Assist Radiol Surg; 2018 Apr 01; 13(4):563-571. PubMed ID: 29270916
    [Abstract] [Full Text] [Related]

  • 12. Prediction of IDH1-Mutation and 1p/19q-Codeletion Status Using Preoperative MR Imaging Phenotypes in Lower Grade Gliomas.
    Park YW, Han K, Ahn SS, Bae S, Choi YS, Chang JH, Kim SH, Kang SG, Lee SK.
    AJNR Am J Neuroradiol; 2018 Jan 01; 39(1):37-42. PubMed ID: 29122763
    [Abstract] [Full Text] [Related]

  • 13. Conventional Magnetic Resonance Features for Predicting 1p19q Codeletion Status of World Health Organization Grade II and III Diffuse Gliomas.
    Peng X, Yishuang C, Kaizhou Z, Xiao L, Ma C.
    J Comput Assist Tomogr; 2019 Jan 01; 43(2):269-276. PubMed ID: 30371623
    [Abstract] [Full Text] [Related]

  • 14. 1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas.
    Zhang Y, Xie Y, He L, Tang J, He Q, Cao Q, Cui L, Guo W, Hua K, Dimberg A, Wang L, Zhang L.
    Cell Oncol (Dordr); 2021 Feb 01; 44(1):193-204. PubMed ID: 32915415
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas.
    Yamauchi T, Ohno M, Matsushita Y, Takahashi M, Miyakita Y, Kitagawa Y, Kondo E, Tsushita N, Satomi K, Yoshida A, Ichimura K, Narita Y.
    Brain Tumor Pathol; 2018 Jul 01; 35(3):148-158. PubMed ID: 29922974
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas.
    Nishikawa T, Ohka F, Aoki K, Suzuki H, Motomura K, Yamaguchi J, Maeda S, Kibe Y, Shimizu H, Natsume A, Innan H, Saito R.
    Brain Tumor Pathol; 2023 Apr 01; 40(2):85-92. PubMed ID: 36991274
    [Abstract] [Full Text] [Related]

  • 19. MRI features predict survival and molecular markers in diffuse lower-grade gliomas.
    Zhou H, Vallières M, Bai HX, Su C, Tang H, Oldridge D, Zhang Z, Xiao B, Liao W, Tao Y, Zhou J, Zhang P, Yang L.
    Neuro Oncol; 2017 Jun 01; 19(6):862-870. PubMed ID: 28339588
    [Abstract] [Full Text] [Related]

  • 20. MRI and CT Identify Isocitrate Dehydrogenase (IDH)-Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ Hybridization.
    Patel SH, Batchala PP, Mrachek EKS, Lopes MS, Schiff D, Fadul CE, Patrie JT, Jain R, Druzgal TJ, Williams ES.
    Radiology; 2020 Jan 01; 294(1):160-167. PubMed ID: 31714193
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 118.